A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer

Shane Stegeman1, Leire Moya1, Luke A Selth2

  • 1School of Biomedical SciencesInstitute of Health and Biomedical Innovation, Translational Research Institute Pty Ltd, Australian Prostate Cancer Research Centre - Queensland, Queensland University of Technology, 37 Kent Street, Woolloongabba, Brisbane, Queensland 4102, AustraliaDame Roma Mitchell Cancer Research LaboratoriesSchool of Medicine, Adelaide Prostate Cancer Research CentreSchool of MedicineFreemasons Foundation Centre for Men's Health, The University of Adelaide, Adelaide, South Australia 5005, AustraliaMolecular Cancer Epidemiology LaboratoryGenetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.

Endocrine-Related Cancer
|February 12, 2015
PubMed

Insights

The oncogene MDM4 is linked to increased prostate cancer risk via the rs4245739 SNP. Specific microRNAs target the C-allele, inhibiting MDM4 translation and affecting cancer progression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The MDM4 oncogene (also known as MDMX or HDMX) plays a role in cancer by suppressing tumor-suppressive genes.
  • A genome-wide association study identified the rs4245739 SNP (A>C) in MDM4's 3'-UTR, with the A-allele associated with higher prostate cancer risk.

Purpose of the Study:

  • To investigate the functional impact of the rs4245739 SNP on MDM4 regulation by microRNAs (miRNAs) in prostate cancer.
  • To elucidate the mechanism by which the rs4245739 SNP A-allele might contribute to prostate cancer susceptibility.

Main Methods:

  • Reporter gene assays and endogenous MDM4 expression analysis were used to assess miRNA binding and effects.
  • Computational predictions identified potential miRNA binding sites at the rs4245739 SNP.
  • Analysis of patient gene expression datasets correlated MDM4 with prostate cancer progression and metastasis.

Main Results:

  • miR-191-5p and miR-887 specifically bind to the rs4245739 SNP C-allele in prostate cancer cells.
  • These miRNAs inhibit MDM4 translation, not mRNA levels, in C-allele-containing PC3 cells.
  • MDM4 expression correlates with metastasis and progression; targeting MDM4 with miR-191-5p or miR-887 reduces PC3 cell viability.

Conclusions:

  • This study demonstrates miRNA-mediated regulation of the MDM4 rs4245739 SNP C-allele in prostate cancer.
  • A mechanism is identified where specific miRNAs targeting the C-allele may explain the association of the A-allele with increased prostate cancer risk.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K